Navigation Links
Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
Date:9/20/2008

- BENEFIT is first and only prospectively planned 5-year study to show long

lasting benefit of early treatment -

MONTREAL, Sept. 20 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today that new data from its BENEFIT (BEtaseron in Newly Emerging multiple sclerosis For Initial Treatment) study confirm that early initiation of Betaseron(R) (interferon beta-1b) treatment in patients with a first event suggestive of multiple sclerosis (MS) significantly delayed the onset of clinically-definite MS (CDMS) by 37 percent (p=0.003) and McDonald MS by 45 percent (p<0.0001) over five years compared to delayed treatment. The results confirm a continued benefit of initiating treatment with Betaseron shortly after the first event.(1) These five-year findings from the BENEFIT study were presented today at the World Congress on Treatment and Research in Multiple Sclerosis (WCTRIMS).

"The BENEFIT five-year results are the first and only prospectively planned data to confirm a continuous benefit over five years when treatment is initiated shortly after the earliest sign of MS," said Dr. Mark Freedman, Professor of Neurology at the University of Ottawa and investigator of the study. "These results confirm that treatment with Betaseron after the first MS event or attack can reduce the risk of developing MS over five years compared to delayed treatment."

The study also demonstrated that early treatment with Betaseron had a beneficial effect on cognition that became even more pronounced over time. At five years, patients with early treatment had better cognitive function (mean PASAT score) compared to patients with delayed treatment (p= 0.0045).(1) PASAT, or the Paced Auditory Serial Addition Test, is a widely accepted tool that measures intellectual function and cognition.

"Changes in cognitive function have important implications for a patient's quality of life. Changes in cognition, along with fatigue, can be a reason for
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
5. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
6. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
7. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
8. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
9. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
10. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
11. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , 17 settembre 2014 Hologic, Inc. ... il lancio in Europa del Tomcat, un nuovo ... una piattaforma multifunzionale completamente automatizzata, progettata per semplificare ... ed i rischi di errore legati alla gestione ... strumento Tomcat di Hologic riduce il carico di ...
(Date:9/16/2014)... Sept. 16, 2014 This report analyzes the worldwide ... Product Segments: Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. ... and Farm Animals. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... of World. Annual estimates and forecasts are provided for the ...
(Date:9/16/2014)... -- A study led by St. Jude Children,s ... threshold below which male childhood cancer survivors are likely ... September 17 edition of the journal Lancet Oncology ... highest risk for reduced sperm production as adults, researchers ... fertility preservation methods such as sperm banking. ...
Breaking Medicine Technology:Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 3Global Animal Medication Industry 2Global Animal Medication Industry 3Global Animal Medication Industry 4Global Animal Medication Industry 5Global Animal Medication Industry 6Global Animal Medication Industry 7Global Animal Medication Industry 8Global Animal Medication Industry 9Global Animal Medication Industry 10Global Animal Medication Industry 11Global Animal Medication Industry 12Global Animal Medication Industry 13Global Animal Medication Industry 14Global Animal Medication Industry 15Global Animal Medication Industry 16Global Animal Medication Industry 17Global Animal Medication Industry 18Global Animal Medication Industry 19Global Animal Medication Industry 20Global Animal Medication Industry 21Global Animal Medication Industry 22Global Animal Medication Industry 23Global Animal Medication Industry 24Global Animal Medication Industry 25Global Animal Medication Industry 26Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4
... Oct. 11, 2011 I-Flow announced ... national purchasing agreement by HealthTrust Purchasing Group, L.P. ... agreement covers I-Flow,s flagship ON-Q® products for incisional, ... ON-Q® PainBuster®, ON-Q® SilverSoaker™ Catheters and ON-Q® disposable ...
... Utah, Oct. 11, 2011 Merit Medical Systems, Inc. ... marketer of proprietary disposable medical devices used in interventional ... announced today that the Company will release its financial ... after the close of the stock market on Tuesday, ...
Cached Medicine Technology:I-Flow LLC, a Kimberly-Clark Health Care Company Announces Agreement for ON-Q® Products With HealthTrust Purchasing Group 2
(Date:9/17/2014)... progressive decline in signal transduction and insulin release, according ... in Sweden. The finding, which is published in the ... underlying age-related impairment of insulin-producing cells and diabetes. , ... many diseases, and type 2 diabetes is no exception. ... of developing type 2 diabetes if their insulin-producing cells ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 The ... serving Westchester, Putnam and Dutchess Counties in New ... clinical affiliation agreement with the Mount Sinai Health ... providing integrated and coordinated care for the communities ... both Mount Sinai and MKMG will work together ...
(Date:9/17/2014)... September 17, 2014 “North America ... market data on the North America Gynecological Devices ... US dollars, volume (in units) and average prices ... Female Sterilization Devices (Transcervical Sterilization ... and Rings)) , Endometrial Ablation Devices ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Lintelus, ... announced today it has released Lintelus Meeting Version ... meetings and corporate events. The newest release includes ... and document management capabilities and allow a more ... , Lintelus Meeting 3.1 offers product advancements ...
(Date:9/17/2014)... Chesterbrook, PA (PRWEB) September 17, 2014 ... costs and increase efficiency. Today, Pharmacy Healthcare Solutions, ... Reporting, a web-based analysis and forecasting tool that ... while maximizing the impact of medications on improved ... TARxGET Reporting uses pharmacy purchase data to identify ...
Breaking Medicine News(10 mins):Health News:Mechanism behind age-dependent diabetes discovered 2Health News:Mount Sinai Health System Partners with Mount Kisco Medical Group to Enhance Health Care Options for Residents of Lower Hudson Valley 2Health News:Mount Sinai Health System Partners with Mount Kisco Medical Group to Enhance Health Care Options for Residents of Lower Hudson Valley 3Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 2Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 3Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 4Health News:Lintelus Energizes Audiences with the Latest Version Of its Multi-Screen Interactive Software 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 3
... ... ... Plastic Surgeons (ASPS) is bringing its popular Hot Topics in Plastic Surgery panel directly to ... can get answers to questions on emerging procedures, trends, and new technologies while engaging in ...
... Oct. 26 With the fall and winter influenza ... Prevention anticipates an even greater impact than the spring ... and businesses affected. SunGard Availability Services today outlined the ... addressed in developing pandemic plans to improve ...
... SOUTH PASADENA, Calif., Oct. 26 An evening under ... hundreds of distinguished guests from the State, local cities ... Cancer Center officially opened with a ceremonial ribbon cutting ... Antonovich and California Assemblymember Ted Lieu paid special recognition ...
... in 30 children and young adults shows good early ... with certain heart defects have impaired blood flow from ... the lungs, requiring implanted devices (known as right-ventricular outflow ... fail over time, and children typically face multiple open-heart ...
... , FARMINGTON HILLS, Mich., Oct. 26 ... flu will cause them to avoid shopping on traditionally busy retail ... Omnibus Study. , This concern stems from a consumer fear of ... the last 12 months. Some of the Morpace respondents indicated that ...
... Research Inc. (TSX:NRI), today responded to a request from ... behalf of the Toronto Stock Exchange following recent trading ... policy not to comment on market rumours or speculation, ... as previously disclosed, it anticipates receiving a decision from ...
Cached Medicine News:Health News:Plastic Surgeons to Discuss Cleavage Rejuvenation, Do-It-Yourself Lasers and Other Hot Topics with the Media 2Health News:SunGard Availability Services Addresses the Business, Operational and Workforce Issues Involved in Pandemic Planning 2Health News:SunGard Availability Services Addresses the Business, Operational and Workforce Issues Involved in Pandemic Planning 3Health News:SunGard Availability Services Addresses the Business, Operational and Workforce Issues Involved in Pandemic Planning 4Health News:South Pasadena Cancer Center Grand Opening Brings State and City Officials Together for an Evening 2Health News:Catheter-Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 2Health News:Catheter-Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 3Health News:Catheter-Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 4Health News:Morpace Reports: H1N1 Flu Could Adversely Impact Holiday Shopping Season 2Health News:Nuvo Research responds to increased trading activity 2
DIX foreign body spud 4 3/4 inches, 1.7 x 15 mm blade....
... MMA/VP material and has a high water content ... the base curve and total diameter as specified ... a power range of -30.00DS to +30.00DS,Simplon Bandage ... therapeutic applications including the controlled on-eye delivery of ...
Foreign body spud very thin, lightly curved and rounded tip....
... Manufactured from premium ... with high oxygen permeability. ... design. Recommended for the ... erosions and abrasions. bullous ...
Medicine Products: